Sykehuset Innlandet HF

At Sykehuset Innlandet HF in Elverum, trials in this area focus on improving treatment approaches and clinical decision-making across several conditions, including postoperative bleeding, central retinal artery occlusion, and precision cancer medicine. The research aims to test new therapies, support better targeting of care, and evaluate how existing treatments can be used more effectively.

• Testing tranexamic acid to reduce bleeding after surgery
• Evaluating tenecteplase for acute eye-related vascular injury
• Advancing precision medicine to match cancer treatment with tumor characteristics

These studies reflect a strong interest in practical, patient-focused innovations that may improve outcomes in both emergency and planned care settings.

Research in cardiovascular disease at this site includes work on urgent vascular events and treatment strategies that may improve recovery and reduce complications. The main focus is on central retinal artery occlusion, where investigators are assessing whether early treatment can improve outcomes after sudden loss of vision.

• Studying treatment response in central retinal artery occlusion
• Exploring faster intervention for acute vascular injury
• Assessing whether a new therapy can improve functional recovery

This work supports better understanding of time-sensitive vascular conditions and the potential value of rapid treatment.

The site is involved in research on eye diseases, especially central retinal artery occlusion, a serious condition that can cause sudden vision loss. The trial activity here is centered on evaluating whether an early treatment approach can improve visual outcomes and reduce the impact of this emergency.

• Investigating treatment for central retinal artery occlusion
• Measuring whether early therapy can protect vision
• Supporting better care for acute ophthalmic emergencies

These studies aim to strengthen evidence for managing rare but severe eye conditions in a timely and effective way.

Cancer studies at Sykehuset Innlandet HF cover both common and hard-to-treat malignancies, including metastatic castration-resistant prostate cancer, non-small cell lung cancer, and other advanced cancers. The trials are designed to test targeted therapies, compare treatment effectiveness, and expand access to promising cancer medicines.

• Evaluating targeted anti-cancer drugs for advanced and biomarker-defined cancers
• Studying treatment options for rare and hard-to-treat cancers
• Comparing new therapies with standard cancer treatment to improve survival and disease control

This research reflects a strong emphasis on precision oncology and on finding more effective options for patients with limited treatment choices.

Clinical trials in neurology at the site address progressive and disabling conditions such as amyotrophic lateral sclerosis and chronic migraine. The studies are focused on slowing disease progression, reducing symptom burden, and improving daily functioning for affected patients.

• Testing treatment approaches for amyotrophic lateral sclerosis
• Evaluating therapies to reduce migraine frequency
• Assessing whether combination treatment can improve symptom control

These projects aim to support better long-term management of neurological disease through more effective and patient-friendly therapies.

Research in this area centers on type 2 diabetes and painful diabetic peripheral neuropathy, a complication that can significantly affect quality of life. The trials are evaluating whether new treatment combinations can reduce neuropathic pain more effectively than placebo.

• Studying pain relief in painful diabetic peripheral neuropathy
• Assessing new options for people living with type 2 diabetes
• Exploring whether treatment can improve comfort and daily function

This work is aimed at improving symptom control in a common metabolic condition with important nerve-related complications.

The site’s mental health research includes studies on major depression disorder and treatment-resistant forms of depression, alongside related work that may overlap with chronic pain and quality-of-life outcomes. Investigators are examining whether maintenance treatment can help sustain improvement in people whose depression has been difficult to treat.

• Evaluating therapies for treatment-resistant depression
• Studying longer-term symptom control in major depression disorder
• Supporting research into more durable mental health treatment strategies

These trials are intended to improve care for patients who need more effective and lasting options for depression management.

Research linked to psychological phenomena at this site includes studies that look beyond disease control to broader patient experience, such as pain relief, symptom burden, and treatment satisfaction. This includes work in migraine, depression, and cancer care, where the goal is to improve how patients feel and function during treatment.

• Measuring patient-reported improvement in migraine and pain studies
• Evaluating quality-of-life impact in depression research
• Supporting treatment choices that better match patient needs and experiences

These trials help connect clinical effectiveness with the everyday experiences of people living with chronic or serious illness.